Stocks in Action USA: AbCellera, Archer Aviation and Monday.com.
Reading Time: 3 minutes
AbCellera (ABCL) Sparks Biotech Excitement: New Hope Against Hot Flashes Impresses! AbCellera has caused a significant stock jump with the Phase 2 data of its experimental drug ABCL635: The non-hormonal antibody was able to reduce the frequency and severity of hot flashes in women with moderate to severe menopausal symptoms much more than a placebo. After four weeks, moderate to severe symptoms decreased on average by 83% compared to the baseline, compared to 33% in the placebo group; symptom severity and sleep also significantly improved. At...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
